Last updated: May 30, 2015
Sponsor: Isfahan University of Medical Sciences
Overall Status: Completed
Phase
2/3
Condition
Tourette's Syndrome
Mood Disorders
Psychosis
Treatment
N/AClinical Study ID
NCT02458924
393230
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of schizophrenia patients and bipolar disorder patients diagnosed accordingto the Diagnostic and Statistical Manual of Mental Disorders version IV criteria
Normal healthy subjects without a psychiatric history
First degree relatives of schizophrenic patients
Exclusion
Exclusion Criteria:
Dermatological lesions, asthma or allergic disease, diabetes, chronic hypertension,vasculitis, substance use disorders (except cigarette smoking), or pregnancy
Taking any oral medication that could affect the metabolism of prostaglandins such asnonsteroidal anti-inflammatory drugs or corticosteroids
Study Design
Total Participants: 100
Study Start date:
January 01, 2014
Estimated Completion Date:
September 30, 2014